Atlas FDA

Radiesse Injectable Implant

FDA premarket approval P050052/S096 · decided 2017-09-18

Approval details

PMA number
P050052
Supplement
S096
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
Radiesse Injectable Implant
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2017-07-17
Decision date
2017-09-18
Days to decision
63 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29